Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (OTC Pink - Current Information:NONOF)

33.15
Delayed Data
As of Dec 02
 -0.10 / -0.30%
Today’s Change
31.07
Today|||52-Week Range
59.40
-42.20%
Year-to-Date
Novo Nordisk's Tresiba Shows Safe Cardiovascular Profile
Nov 30 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for November 28th
Nov 28 / Zacks.com - Paid Partner Content
3 High-Yield Dividend Stocks to Buy in December
Nov 30 / MotleyFool.com - Paid Partner Content
Novo Nordisk's Diabetes Combination Drug Gets FDA's Nod
Nov 23 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close33.25
Today’s open33.11
Day’s range33.11 - 33.15
Volume3,005
Average volume (3 months)127,026
Market cap$66.9B
Dividend yield2.79%
Data as of 10:08am ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+12.17%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+1.54%
P/E ratio--
Price/Sales9.35
Price/Book12.39

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$16.0B
Annual profit (last year)$5.2B
Net profit margin32.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Rebien Sørensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts


Search for Jobs